Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Royal Medical Services, |
RCV000789127 | SCV005068370 | likely pathogenic | Giant axonal neuropathy 1 | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000789127 | SCV005839053 | pathogenic | Giant axonal neuropathy 1 | 2024-10-10 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 545 of the GAN protein (p.Arg545His). This variant is present in population databases (rs746486469, gnomAD 0.03%). This missense change has been observed in individual(s) with giant axonal neuropathy (PMID: 17587580, 19295179, 23248352, 30246730). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 637092). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. |
Inherited Neuropathy Consortium | RCV000789127 | SCV000928478 | uncertain significance | Giant axonal neuropathy 1 | no assertion criteria provided | literature only | ||
Inherited Neuropathy Consortium Ii, |
RCV000789127 | SCV004174502 | uncertain significance | Giant axonal neuropathy 1 | 2016-01-06 | no assertion criteria provided | literature only |